X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16304) 16304
Book Review (1854) 1854
Newsletter (1191) 1191
Publication (535) 535
Newspaper Article (106) 106
Conference Proceeding (97) 97
Magazine Article (79) 79
Dissertation (51) 51
Book Chapter (20) 20
Trade Publication Article (18) 18
Web Resource (6) 6
Reference (3) 3
Report (3) 3
Book / eBook (2) 2
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11795) 11795
omeprazole (11086) 11086
humans (10289) 10289
male (6936) 6936
female (5883) 5883
gastroenterology & hepatology (4682) 4682
middle aged (4593) 4593
adult (4427) 4427
omeprazole - therapeutic use (3929) 3929
proton pump inhibitors (3492) 3492
pharmacology & pharmacy (3325) 3325
aged (3105) 3105
anti-ulcer agents - therapeutic use (2813) 2813
helicobacter pylori (2551) 2551
helicobacter infections - drug therapy (2426) 2426
lansoprazole (2419) 2419
omeprazole - administration & dosage (2184) 2184
2-pyridinylmethylsulfinylbenzimidazoles (2132) 2132
animals (2108) 2108
omeprazole - analogs & derivatives (2024) 2024
treatment outcome (2005) 2005
omeprazole - pharmacology (1909) 1909
drug therapy, combination (1904) 1904
abridged index medicus (1716) 1716
anti-ulcer agents - administration & dosage (1423) 1423
gastroesophageal reflux - drug therapy (1400) 1400
ranitidine (1392) 1392
therapy (1324) 1324
rats (1264) 1264
gastroesophageal reflux (1239) 1239
omeprazole - adverse effects (1194) 1194
infection (1142) 1142
adolescent (1106) 1106
hydrogen-ion concentration (1102) 1102
prospective studies (1072) 1072
medicine, general & internal (1045) 1045
time factors (1015) 1015
anti-bacterial agents - therapeutic use (986) 986
double-blind method (986) 986
eradication (981) 981
proton pump inhibitor (977) 977
rabeprazole (970) 970
aged, 80 and over (944) 944
helicobacter pylori - drug effects (936) 936
pantoprazole (924) 924
pharmacokinetics (908) 908
anti-ulcer agents - pharmacology (895) 895
amoxicillin - therapeutic use (879) 879
duodenal ulcer - drug therapy (878) 878
disease (876) 876
amoxicillin (861) 861
drug interactions (859) 859
dose-response relationship, drug (842) 842
duodenal-ulcer (824) 824
research (815) 815
drug administration schedule (781) 781
drugs (771) 771
proton pump inhibitors - therapeutic use (767) 767
clarithromycin - therapeutic use (765) 765
double-blind (754) 754
risk factors (752) 752
peptic ulcer - drug therapy (746) 746
recurrence (741) 741
gastric mucosa - drug effects (740) 740
clarithromycin (730) 730
gastroesophageal reflux disease (728) 728
esophagitis (719) 719
anti-ulcer agents - adverse effects (714) 714
gastric acid - secretion (702) 702
medicine & public health (698) 698
follow-up studies (692) 692
gastric acid - metabolism (682) 682
helicobacter infections - complications (672) 672
efficacy (669) 669
stomach ulcer - drug therapy (657) 657
care and treatment (655) 655
esomeprazole (649) 649
amoxicillin - administration & dosage (643) 643
management (635) 635
histamine h2 antagonists - therapeutic use (627) 627
administration, oral (626) 626
gastroesophageal reflux - complications (615) 615
drug therapy (610) 610
omeprazole - pharmacokinetics (592) 592
triple therapy (587) 587
surgery (571) 571
analysis (569) 569
enzyme inhibitors - therapeutic use (569) 569
anti-bacterial agents - administration & dosage (566) 566
ranitidine - therapeutic use (551) 551
prevalence (547) 547
clarithromycin - administration & dosage (542) 542
gastroesophageal-reflux disease (537) 537
proton pump inhibitors - adverse effects (537) 537
helicobacter pylori - isolation & purification (535) 535
gastrins - blood (532) 532
benzimidazoles - therapeutic use (525) 525
risk (515) 515
cross-over studies (514) 514
gastric mucosa - pathology (504) 504
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15933) 15933
German (399) 399
Spanish (354) 354
French (277) 277
Japanese (249) 249
Russian (165) 165
Chinese (82) 82
Italian (57) 57
Portuguese (48) 48
Korean (46) 46
Polish (33) 33
Swedish (23) 23
Dutch (20) 20
Turkish (18) 18
Czech (15) 15
Danish (13) 13
Ukrainian (13) 13
Hungarian (12) 12
Norwegian (10) 10
Finnish (4) 4
Croatian (3) 3
Slovak (3) 3
Bosnian (2) 2
Bulgarian (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Persian (2) 2
Romanian (2) 2
Serbian (2) 2
Slovenian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Der Hautarzt, ISSN 0017-8470, 02/2018, Volume 69, Issue 2, p. 162
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00105-017-4075-4... 
Omeprazole
Journal Article
Equine Veterinary Journal, ISSN 0425-1644, 09/2017, Volume 49, Issue S51, pp. 25 - 26
Journal Article
Journal of Equine Veterinary Science, ISSN 0737-0806, 05/2017, Volume 52, pp. 101 - 102
Journal Article
Equine Veterinary Journal, ISSN 0425-1644, 09/2014, Volume 46, Issue S47, pp. 22 - 22
To compare the pharmacokinetics and bioavailability of 4 commercially available formulations of omeprazole to an existing reference formulation. A single dose... 
Omeprazole
Journal Article
Equine Veterinary Journal, ISSN 0425-1644, 09/2016, Volume 48, Issue S50, pp. 11 - 11
Journal Article
World Allergy Organization Journal, ISSN 1939-4551, 04/2015, Volume 8, Issue 135
Journal Article
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 7/2013, Volume 69, Issue 7, pp. 1423 - 1428
Omeprazole has (R)- and (S)-enantiomers, which exhibit different pharmacokinetics (PK) among patients with cytochrome P450 (CYP) 2C19 genotype groups. The aim... 
( S )-5-hydroxyomeprazole | ( R )-5-hydroxyomeprazole | Hydroxylation index | Biomedicine | ( S )-omeprazole | Pharmacology/Toxicology | CYP2C19 | ( R )-omeprazole | (S)-5-hydroxyomeprazole | (S)-omeprazole | (R)-5-hydroxyomeprazole | (R)-omeprazole | OMEPRAZOLE METABOLISM | 4'-HYDROXYLATION | PROTON PUMP INHIBITORS | GENOTYPES | S-MEPHENYTOIN | THERAPY | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | ERADICATION | HUMAN CYTOCHROME-P450 ENZYMES | HELICOBACTER-PYLORI | Exons | Stereoisomerism | Humans | Omeprazole - blood | Aryl Hydrocarbon Hydroxylases - genetics | Anti-Ulcer Agents - blood | Chromatography, High Pressure Liquid | Drug Monitoring - methods | Anti-Ulcer Agents - pharmacokinetics | Proton Pump Inhibitors - blood | Genetic Association Studies | Hydroxylation | Japan | Omeprazole - pharmacokinetics | Aryl Hydrocarbon Hydroxylases - metabolism | Polymorphism, Genetic | Pilot Projects | Anti-Ulcer Agents - chemistry | Proton Pump Inhibitors - chemistry | Proton Pump Inhibitors - pharmacokinetics | Cytochrome P-450 CYP2C19 | Metabolic Detoxication, Phase I | Omeprazole - chemistry | Alleles | Omeprazole - analogs & derivatives | Omeprazole | Metabolites | Analysis | Cytochrome P-450 | Liquid chromatography | Enantiomers | Genotype & phenotype | Pharmacology | Drug therapy | Gastroenterology | Index Medicus
Journal Article
Inflammation Research, ISSN 1023-3830, 03/2007, Volume 56, Issue 3, p. 105
This study investigated the ability of proton pump inhibitors (PPI), such as omeprazole and pantoprazole, to inhibit neutrophil migration, calcium mobilization... 
Omeprazole
Journal Article
Journal of Technology Management & Innovation, ISSN 0718-2724, 2010, Volume 5, Issue 3, pp. 110 - 119
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 01/2011, Volume 89, Issue 1, pp. 65 - 74
Four randomized, placebo‐controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between... 
VARIABILITY | LANSOPRAZOLE | RABEPRAZOLE | THERAPY | CARDIOVASCULAR EVENTS | STENT PLACEMENT | PHARMACOLOGY & PHARMACY | OUTCOMES | ANTIPLATELET ACTION | PROTON-PUMP INHIBITORS | DRUG-INTERACTION | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Middle Aged | Half-Life | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Enzyme Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Omeprazole - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Enzyme Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects | Ticlopidine - analogs & derivatives | Cross-Over Studies | Prodrugs - adverse effects | Prodrugs - pharmacokinetics | Cytochrome P-450 CYP2C19 | Platelet Activation - drug effects | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Prodrugs - pharmacology | Ticlopidine - blood | Omeprazole | Pantoprazole | Drug interactions | Analysis | Dosage and administration | Research | Patients | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Chromatography A, ISSN 0021-9673, 2007, Volume 1156, Issue 1, pp. 201 - 205
To guarantee that an analytical procedure gives reliable, exact and interpretable information about a sample, it must be validated. Two ambiguous parameters... 
Validation | Quantification limit | Impurities in omeprazole | Detection limit | Uncertainty | 2-Pyridinylmethylsulfinylbenzimidazoles - analysis | Omeprazole - standards | Chromatography, High Pressure Liquid | Drug Contamination | Omeprazole - analogs & derivatives | Omeprazole - analysis | Index Medicus
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 09/2014, Volume 96, Issue 3, pp. 349 - 359
The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and... 
P4502B6 ACTIVITY | VORICONAZOLE | LC-MS/MS | SINGLE-POINT | ORAL MIDAZOLAM | VOLUNTEERS | IN-VIVO | PHARMACOLOGY & PHARMACY | DRUG-METABOLIZING-ENZYMES | KAROLINSKA COCKTAIL | BUPROPION HYDROXYLATION | Predictive Value of Tests | Pharmaceutical Preparations - blood | Caffeine - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Dried Blood Spot Testing | Humans | Omeprazole - blood | Bupropion - blood | Midazolam - administration & dosage | Substrate Specificity | Male | Chromatography, High Pressure Liquid | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Coffee | Terfenadine - administration & dosage | Caffeine - pharmacokinetics | Feasibility Studies | Enzyme Inhibitors - administration & dosage | Young Adult | Chromatography, Reverse-Phase | Tandem Mass Spectrometry | Capsules | Spectrometry, Mass, Electrospray Ionization | Flurbiprofen - administration & dosage | Adult | Dextromethorphan - pharmacokinetics | Terfenadine - blood | ATP-Binding Cassette, Sub-Family B, Member 1 - blood | Pharmaceutical Preparations - administration & dosage | Terfenadine - pharmacokinetics | Bupropion - pharmacokinetics | Flurbiprofen - pharmacokinetics | Cytochrome P-450 Enzyme System - blood | Administration, Oral | Isoenzymes | Caffeine - blood | Omeprazole - administration & dosage | Terfenadine - analogs & derivatives | Omeprazole - pharmacokinetics | Carbonated Beverages | Midazolam - pharmacokinetics | Bupropion - administration & dosage | Dextromethorphan - blood | Flurbiprofen - blood | Phenotype | Pilot Projects | Midazolam - blood | Dextromethorphan - administration & dosage | Usage | Glycoproteins | Liquid chromatography | Research | Pharmacokinetics | Cytochrome P-450 | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2009, Volume 53, Issue 3, pp. 958 - 966
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CELL TRANSPLANT RECIPIENTS | STEADY-STATE PHARMACOKINETICS | BEVERAGE COCA-COLA | SALVAGE THERAPY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | FOOD INTERACTION | INVASIVE FUNGAL-INFECTION | ITRACONAZOLE | TRIAZOLE ANTIFUNGAL | VERSUS-HOST-DISEASE | FLUCONAZOLE | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Triazoles - blood | Area Under Curve | Humans | Middle Aged | Omeprazole - blood | Intestinal Absorption - drug effects | Male | Anti-Ulcer Agents - blood | Gastric Mucosa - metabolism | Anti-Ulcer Agents - pharmacokinetics | Dose-Response Relationship, Drug | Young Adult | Antifungal Agents - pharmacokinetics | Hydrogen-Ion Concentration - drug effects | Gastric Mucosa - drug effects | Adult | Female | Triazoles - pharmacokinetics | Suspensions | Eating | European Continental Ancestry Group - genetics | Fasting | Drug Administration Schedule | Administration, Oral | Food-Drug Interactions | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | African Americans - genetics | European Continental Ancestry Group - statistics & numerical data | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Carbonated Beverages | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | African Americans - statistics & numerical data | Antifungal Agents - administration & dosage | Antifungal Agents - blood | Index Medicus | Pharmacology
Journal Article
Equine Veterinary Education, ISSN 0957-7734, 07/2017, Volume 29, Issue S8, pp. 19 - 19
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2010, Volume 363, Issue 20, pp. 1909 - 1917
Journal Article